CSF2 and melanoma: In the mouse B16 melanoma model, irradiated tumor cells expressing GM-CSF, acted as a vaccine, inducing potent, long lasting T cell dependent tumor-specific immunity [152], identifying it as a promising immune modulatory candidate for arming oHSVs.